FAT1 mutation + FAT1 underexpression + IRS1 overexpression
|
SCCHN
|
FAT1 mutation + FAT1 underexpression + IRS1 overexpression
|
SCCHN
|
Immunotherapy Resistant: C3 – Early Trials
|
Immunotherapy Resistant: C3 – Early Trials
|
FAT1 mutation + FAT1 underexpression + IRS1 overexpression
|
SCCHN
|
FAT1 mutation + FAT1 underexpression + IRS1 overexpression
|
SCCHN
|
EGFR inhibitor Resistant: C3 – Early Trials
|
EGFR inhibitor Resistant: C3 – Early Trials
|